The UK plans to test US firm Eli Lilly’s weight-loss jab Mounjaro to help the burden on the national health care system. Over a quarter of UK adults suffered from obesity in 2023, according to government data.

The United Kingdom plans to trial the use of weight-loss drugs to help unemployed people with obesity get back to work, British Health Minister Wes Streeting said on Tuesday.

London’s plans to test US firm Eli Lilly’s Mounjaro jab comes amid the rising popularity of the diabetes medication Ozempic and Wegovy from Danish pharma giant Novo Nordisk to treat obesity.

  • douglasg14b@lemmy.world
    link
    fedilink
    English
    arrow-up
    21
    ·
    edit-2
    2 months ago

    They are 55th on the list for obesity rates.

    It’s a worldwide epidemic unfortunately.

    For reference:

    • U.S. is 10th with 41%
    • Australia is 36th with 32%